Friday, 18 May 2012
Action Duchenne wins Good Cause Award!! - View News Article - Action Duchenne - Fighting for a cure for muscular dystrophy
Action Duchenne wins Good Cause Award!! - View News Article - Action Duchenne - Fighting for a cure for muscular dystrophy: Action Duchenne receives Good Cause Award from Bettys Tea Room, York. The Good Cause Award is a community grant of �500 awarded on the basis of supporting local families. We would like to thank the team at Bettys for their fantastic support.
Tuesday, 15 May 2012
Study identifies how skeletal muscle stem cells respond to muscle injury
Study identifies how skeletal muscle stem cells respond to muscle injury: A study conducted by Children's Hospital & Research Center Oakland scientists identifies how skeletal muscle stem cells respond to muscle injury and may be stimulated to improve muscle repair in Duchenne Muscular Dystrophy, a severe inherited disease of muscle that causes weakness, disability and, ultimately, heart and respiratory failure.
Tuesday, 8 May 2012
U of M researchers develop new muscular dystrophy treatment approach using human stem cells | Science Codex
U of M researchers develop new muscular dystrophy treatment approach using human stem cells | Science Codex: The research, published today in Cell Stem Cell, outlines the strategy for the development of a rapidly dividing population of skeletal myogenic progenitor cells (muscle-forming cells) derived from induced pluripotent (iPS) cells. iPS cells have all of the potential of embryonic stem (ES) cells, but are derived by reprogramming skin cells. They can be patient-specific, which renders them unlikely to be rejected, and do not involve the destruction of embryos.
This is the first time that human stem cells have been shown to be effective in the treatment of muscular dystrophy.
This is the first time that human stem cells have been shown to be effective in the treatment of muscular dystrophy.
PPMD Holds Landmark Meeting with FDA Leaders to Address Trial Design, Endpoint,... -- HACKENSACK, N.J., May 3, 2012 /PRNewswire-USNewswire/ --
PPMD Holds Landmark Meeting with FDA Leaders to Address Trial Design, Endpoint,... -- HACKENSACK, N.J., May 3, 2012 /PRNewswire-USNewswire/ --: "The recent PPMD-FDA leadership meeting provides a solid foundation upon which we can build to develop and implement the tools and processes necessary to expedite the FDA's review of potential treatments and accelerate the delivery of safe and effective treatments to our patients," Furlong said.
"FDA leaders provided valuable information and perspectives on trial design and surrogate endpoint acceptance, two critically important issues, and expressed a desire to continue the discussion with industry leaders. PPMD looks forward to working with FDA to convene a larger roundtable discussion and other follow-up activities on these issues in the coming months, and will work with all patients and Duchenne stakeholders to ensure the community's voice is well-represented at these events."
"FDA leaders provided valuable information and perspectives on trial design and surrogate endpoint acceptance, two critically important issues, and expressed a desire to continue the discussion with industry leaders. PPMD looks forward to working with FDA to convene a larger roundtable discussion and other follow-up activities on these issues in the coming months, and will work with all patients and Duchenne stakeholders to ensure the community's voice is well-represented at these events."
Results from DuchenneConnect Study - PPMD Webinar Follow up - PPMD Community
Results from DuchenneConnect Study - PPMD Webinar Follow up - PPMD Community: Please see the list of Q&A's following the webinar video below, and�let me know if you have any additional follow up questions!
End of season Score4Duchenne Support - View News Article - Action Duchenne - Fighting for a cure for muscular dystrophy
End of season Score4Duchenne Support - View News Article - Action Duchenne - Fighting for a cure for muscular dystrophy: Some of you may recall that Dundee FC Supporters Society kindly helped to support our Score4Duchenne appeal on Boxing Day.Today is the final day of the season and to celebrate and thank everyone involved with Dundee FC Supporters Society Community Project Action Duchenne will join other charities today at Dens Park.
At half time each of the charities from throughout the season will go onto the pitch bearing their own flag, kindly sponsored by Dundee FC, led by the Fintry Pipe Band to visually show the many good causes hosted this season and raise further awareness for the charities.
At half time each of the charities from throughout the season will go onto the pitch bearing their own flag, kindly sponsored by Dundee FC, led by the Fintry Pipe Band to visually show the many good causes hosted this season and raise further awareness for the charities.
Tuesday, 1 May 2012
MARTIN BASHIR, the TV journalist, explains why he’s backing the search for a cure for Duchenne muscular dystrophy.
Martin has become patron of Action Duchenne, the UK muscular dystrophy charity which campaigns for a cure and improved treatments for the cruel muscle-wasting condition which claimed the life of his brother Tommy whom he describes as “the most influential person in my life”.
Subscribe to:
Posts (Atom)